How carbapenem-resistant Acinetobacter spp. established in a newly constructed hospital

International Journal of Antimicrobial Agents

Volumn 31, Issue 5, 2008, Pages 463-466

  Lu, Po Liang ^a,b   Huang, Li Yueh ^c   Lian, Shen Tsuen ^d   Chang, Ko ^d   Lin, Chun Lu ^d   Hwang, In Jane ^d   Chiang, Wen Gin ^a   Chen, Yen Hsu ^a,d   Lin, Sheng Fung ^a   Siu, L K ^c  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

Acinetobacter spp; Carbapenem; Resistance

Indexed keywords

CARBAPENEM;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIUM ISOLATION; CHILD; CLINICAL ARTICLE; DNA FLANKING REGION; DRUG USE; GENE SEQUENCE; HOSPITAL; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INTEGRON; PRIORITY JOURNAL; RIBOTYPING; TAIWAN;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DNA, BACTERIAL; HOSPITALS; HUMANS; INTEGRONS; MIDDLE AGED; TAIWAN;

EID: 42149109591     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.01.019     Document Type: Article

References (14)

1. Lauderdale T.L., Clifford M.L., Shiau Y.R., Chen P.C., Wang H.Y., Lai J.F., et al. The status of antimicrobial resistance in Taiwan among Gram-negative pathogens: the Taiwan surveillance of antimicrobial resistance (TSAR) program, 2000. Diagn Microbiol Infect Dis 48 (2004) 211-219
2. Lee C.M., Lim H.K., Liu C.P., and Tseng H.K. Treatment of pan-drug resistant Acinetobacter baumannii. Scand J Infect Dis 37 (2005) 195-199
3. Krawczyk B., Lewandowski K., and Kur J. Comparative studies of the Acinetobacter genus and the species identification method based on the recA sequences. Mol Cell Probes 16 (2002) 1-11
4. WHO Collaborating Center for Drug Statistics and Methodology. Anatomical Therapeutic Chemical (ATC) Classification Index with Defined Daily Doses (DDDs) for Plain Substances (2001), WHO Collaborating Center for Drug Statistics and Methodology, Oslo, Norway
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Seventeenth informational supplement. M100-S17. Wayne, PA: CLSI; 2007.
6. Franklin C., Liolios L., and Peleg A.Y. Phenotypic detection of carbapenem-susceptible metallo-beta-lactamase-producing Gram-negative bacilli in the clinical laboratory. J Clin Microbiol 44 (2006) 3139-3144
7. Koeleman J.G., Stoof J., Van Der Bijl M.W., Vandenbroucke-Grauls C.M., and Savelkoul P.H. Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR. J Clin Microbiol 39 (2001) 8-13
8. Levesque C., Piche L., Larose C., and Roy P.H. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 39 (1995) 185-191
9. Woodford N., Ellington M.J., Coelho J.M., Turton J.F., Ward M.E., Brown S., et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27 (2006) 351-353
10. IMP) in Gram-negative rods resistant to broad-spectrum beta-lactams. J Clin Microbiol 34 (1996) 2909-2913
11. Turton J.F., Ward M.E., Woodford N., Kaufmann M.E., Pike R., Livermore D.M., et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 258 (2006) 72-77
12. Liu S.Y., Lin J.Y., Chu C., Su L.H., Lin T.Y., and Chiu C.H. Integron-associated imipenem resistance in Acinetobacter baumannii isolated from a regional hospital in Taiwan. Int J Antimicrob Agents 27 (2006) 81-84
13. Pagniez G., Radice M., Cuirolo A., Rodriguez O., Rodriguez H., Vay C., et al. Prevalence of metallo-beta-lactamase in carbapenem resistant Pseudomonas aeruginosa at a university hospital of Buenos Aires City. Rev Argent Microbiol 38 (2006) 33-37 [in Spanish]
14. Tysall L., Stockdale M.W., Chadwick P.R., Palepou M.F., Towner K.J., Livermore D.M., et al. IMP-1 carbapenemase detected in an Acinetobacter clinical isolate from the UK. J Antimicrob Chemother 49 (2002) 217-218